Research Article

Effect of Chelidonium majus L. Root Extract on Cyclophosphamide-Induced Testicular Toxicity in Rats

Amer Hakeem Chyad1, Omar S.I. Al-Janabi2*, Orooba Mohammed Saeed Ibrahim1, Najeeb Mohaamed Hussein3

1Department of Physiology and Pharmacology, College of Veterinary Medicine, Baghdad University, Iraq; 2Department of pharmacology, College of Medicine, University of Al-Anbar, Iraq; 3Department of Food Sciences, Collage of Agriculture, University of Anbar, Iraq.

Received | April 28, 2023; Accepted | May 25, 2023; Published | December, 26, 2023

*Correspondence | Omar S.I. Al-Janabi, Department of pharmacology, College of Medicine, University of Al-Anbar, Iraq; Email: dr.osin1981@uoanbar.edu.iq

Citation | Chyad AH, Al-Janabi OSI, Ibrahim OMS, Hussein NM (2024). Effect of Chelidonium majus L. root extract on cyclophosphamide-induced testicular toxicity in rats. Adv. Anim. Vet. Sci., 12(1):69-76.

DOI | https://dx.doi.org/10.17582/journal.aavs/2024/12.1.69.76

ISSN (Online) | 2307-8316

Copyright: 2024 by the authors. Licensee ResearchersLinks Ltd, England, UK.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Introduction

Cyclophosphamide (CP) has been used to treat breast cancer, ovarian cancer, melanoma, and non-Hodgkin’s lymphoma. According to clinical studies (Falzone et al., 2018), in addition to being an effective chemotherapy medicine for a variety of malignancies. it also has significant anti-proliferative effects, has been extensively tested throughout the world and the United States, and is considered a relatively safe drug It is an alkylating nitrogen mustard anticancer agent (Saha et al., 2019). In addition, a prodrug that is transformed into the active metabolite in the liver (Takimoto and Calvo, 2005). It is promptly absorbed after oral administration and then converted to potent metabolites in the liver (cytochrome P450 system) (Petr et al., 2011). A potent CP metabolite. Practically protein-safe and present in all tissues, it can cross the placenta and is considered a breast milk mediator. When renal impairment is present, medication dosage can be adjusted appropriately because metabolites are primarily excreted unchanged in the urine (Huynh et al., 2020). In conjunction with other chemotherapeutic drugs, CP is used to prevent various forms of lymphomas, leukemia, some solid tumors, and brain cancer. It is a chemotherapeutic medication that causes some cells to die (T cells). The dose-dependent nature of CP’s organic activities (Nelius, et al., 2010).

DNA harm active metabolites of CP include acrolein and phosphoramide mustard, both of which are cytotoxic alkylating agents and, respectively, are responsible for cell cytotoxicity. Phosphoramide mustard results in DNA cross-linking and cell demise. (Groehler et al., 2016). possesses potent immunosuppressive properties and is used to treat chronic autoimmune disorders like systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis (McGaha et al., 2012). CP is a charity that treats malignancies and autoimmune diseases. It is utilised to quickly regulate the disease. Numerous adverse effects, including reproductive toxicity, are associated with CP, which has numerous clinical applications (Kasper et al., 2005). CP reduces luteinizing hormones, follicle-stimulating hormones, testosterone, and spermatogenesis, according to studies (Johari et al., 2011). The majority of chemotherapy medications harm healthy cells in a variety of ways. Cyclophosphamide possesses powerful anticancer properties. Gonadal toxicity is a prevalent side effect of cyclophosphamide therapy, which is used to treat a variety of diseases (Dollery, 1999). Because oxidative pressure causes biochemical and physiological damage, CP is deleterious to the testis and spermatozoa (Selvakumar et al., 2005a). Chelidonium majus L. (Papaveraceae juss) is a valuable herb that is extensively utilised in North America, Europe, Asia, and Northwest Africa. It is considered a native species in Latvia and is found as isolated specimens and extensive growths throughout the United States. In traditional medicine, C. majus has been used to treat bile and liver disorders, as well as warts, corns, fungal infections, dermatitis, and skin lesions. Additionally, plant latex has been applied topically (Barnes et al., 2007; Biswas, 2013). According to Latvian folklore, fresh latex and Chelidonium majus L. tea are used to treat diarrhoea, ocular problems, and skin diseases, as well as lichen and warts (Sile et al., 2020). In numerous ethnobotanical investigations throughout Europe, the treatment of ophthalmological, gastrointestinal, and skin disorders is mentioned (Menkovic et al., 2011; Fortini et al., 2016; Kujawska et al., 2017). The European Medicines Agency (EMA) has proposed potential therapeutic indications in the monograph for chelidonii herbal for the symptomatic relief of digestive issues such as dyspepsia and flatulence (oral administration) and for the treatment of warts, calluses, and corns (cutaneous application) (European Medicines Agency, 2021). Isoquinoline alkaloids isolated from Chelidonium majus extracts were discovered to be numerous of the most potently active molecules for bacteria, viruses, fungi, and protozoa. This disposition of compounds is trifling customarily flip phenanthridine, protoberberine, and protopine derivatives, roots are richer in these compounds (Zielin’ska et al., 2019), however the European pharmacopoeia (European Pharmacopoeia 9th Print Run, 2019) alone refers to the alkaloid qualification of herbs (which endeavour to yell be incomparably yon than zero to 6% and is calculated in phrases of chelidonine content material). In take care of take the approachable pamphlets, tribe is composed of calm down and numerous abbreviated alkaloids, while the aerial portions contain 0.1–1% alkaloids (excluding coptisine, which is abundant in sufficient quantities, particularly in fruits). Due to differences in their molecular structures, C. majus alkaloids exhibited synergy in modifying rudimentary activities (Zieli’nska et al., 2018) quaternary nitrogen in molecules, such as chelerythrine, sanguinarine, berberine, or coptisine, has been found to be enthusiastic arranged the check b determine of solution respiratory, to the fullest extent a finally the air of an imine moiety in the systems of sanguinarine and chelerythrine determines the ability of these compounds to inhibit the pastime of proteins and enzymes (Barreto et al., 2003). Cyclophosphamide has various adverse effects on different organs including the male reproductive system and can cause infertility. Therefore, it is used Chelidonium majus L roots in this to decrease side effects of drug.

Materials and Methods

Preparation of Chelidonium majus L. roots extract

Chelidonium majus L. root hydroethanol alcohol extract was prepared according to the method described by (Chyad, 2017) using Soxhlet apparatus to heat extract plants at a concentration of 70%. The apparatus consists of several components: A heater, a glass flask for the solvent, an extraction unit set on top of the flask and containing a thimble-shaped cup of cellulose in which the Chelidonium majus L. root powder is placed, and a distillation unit. The final distiller passes chilly water through for condensation. The extraction procedure is initiated by heating the solvent to 50 °C in the glass beaker, and the vapour rises through a tube connecting the beaker and the distillation unit. The extraction unit has a cavity, and the solvent and plant materials dissolved in it are withdrawn to the beaker by syphoning. The procedure is repeated until the solvent collected in the extraction unit becomes transparent. Concentrate the extract in a vacuum rotary evaporator at 45°C, and then place the concentrate in Petridish containers to dry the powder. The extract was collected and stored in a freezer at -20 degrees Celsius until use.

Animals

This study was conducted at the University of Baghdad’s Department of Physiology, Biochemistry, and Pharmacology, College of Veterinary Medicine. 30 adult male mice, 3 months of age, evenly weighted between 190 and 220 g, were housed in a temperature range of 22 to 25 degrees celsius in a suitable environmental setting. Seven days prior to the experiment, the rats were confined in plastic cages in an animal house in order to acclimatize them. They had free access to standard pellets and potable water, under standard circumstances and according to university guidelines, all animals in each group were sacrificed and anesthetized according to the ethical guidelines of the Medical Ethical Committee of the National Research Centre in Iraq (IAEC, 2010).

Experimental design

Fifty adult male mice were divided equally into five groups; the period of treatment was thirty days, given orally by stomach tube as follows:

The first group (G1): The animals in this group were intubated with distilled water only (negative control group).

The second group (G2): This group’s animals received cyclophosphamide at 14.2 mg/kg/B.W. (positive control group).


The third group (G3): This group’s animals received Chelidonium majus L. root extract at a dose of 200 mg/kg/B.W. and 14.2 mg/kg/B.W. cyclophosphamide, given orally by stomach tube (Manikowska et al 2014).

The fourth group (G4): This group’s animals received Chelidonium majus L. root extract at a dose of 300 mg/kg/B.W. and 14.2 mg/kg/B.W. cyclophosphamide, given orally by stomach tube (Naglaa et al., 2022).

The five group (G5): This group’s animals received Chelidonium majus L. root extract at a dose of 400 mg/kg/B.W. and 14.2 mg/kg/B.W. cyclophosphamide, given orally by stomach tube (Manikowska et al., 2014).

The cyclophosphamide was given after 24 hours. Chelidonium majus L. root extract was administered once daily for thirty (30) days. At the completion of the treatment, the rats were anaesthetized by inhalation with diethyl ether and sacrificed (Hosseini et al., 2010).

Sperm concentration

Sperm counts were performed according to Sakamoto and Hashimoto (1986). Use a hemocytometer (Neubauer type). The side of the hemocytometer is filled with 5 µl of sperm suspension and covered with a cover slip; sperm are counted in 25 small squares of the chamber Sperm estimates are based on the following formula:

Sperm concentration = Number of sperm X 10000.

Blood collection

After the finish of the experiment, ketamine was used to anesthetize of animal. Each anesthetized animal’s heart was punctured using a single-use insulin syringe to obtain blood samples. After 15 minutes of centrifugation at 2500 rpm, store serum samples in the refrigerator (-18°C) until use.

Serum testosterone levels

After samples were treated with I125 (a labelled testosterone tracer), the hormone testosterone levels were measured using a radioimmunoassay (RIA) kit, and the correlation between I125 and testosterone hormone was calculated in ng/mL using a gamma counter.

Serum FSH and LH levels

The determination of circulating serum concentrations of FSH and LH were done in each control and treatment group by the quantitative analysis using an enzyme - linked immunosorbent assay (ELISA Kits).

Statistical analysis

The statistical analysis of the data was performed using SAS (Statistical Analysis System, Version 9.1). Perform an ANOVA and post hoc least significant difference (LSD) test to determine significant differences between means. Results are expressed as mean, standard error, and percentage. P0.05 was considered statistically significant (SAS, 2014).

Results and Discussion

Effect of Chelidonium majus L. Roots extracts on sperm count

It was observed clearly from Table 1 that sperm count was significantly decreased (P 0.05) in the treated group with cyclophosphamide (135124027.23) in comparison with the control negative group (214520038.27), while significantly increased (P 0.05) in the treated group with Chelidonium majus L. Roots extracts at doses 200mg (223143016.26), 300 mg (235324038.27), and 400 mg (2734328±12.12) as opposed to the control positive group treated with cyclophosphamide at dose 14.2 mg/kg (135124027.23).

 

Table 1: Effect Chelidonium majus L. Roots extracts on Sperm count, total testosterone levels, FSH and LH.

Group	Sperm count / ml	Total testosterone (ng/ml)	FSH (Iu/L)	LH (Iu/L)
Control (-ve)	2145200±38.27B	0.15± 1.83B	0.70± 13.24B	0.51±1.95B
Control (+ve)	1751240±27.23A	0.22±0.91A	0.47± 8.33A	0.26 ±0.95A
Ch. Majus roots (200mg/B.W.)	2231430±16.26B	0.90±1.79B	0.35±13.58B	0.65±1.84B
Ch. Majus roots (300mg/B.W.)	2353240±38.27B	0.44± 2.11BC	0.52± 15.69C	0.11± 2.33C
Ch. Majus roots (400mg/B.W.)	2734328±12.12C	0.28±3.35C	0.30±16.27D	0.11±2.79CD
LSD	2.6924	1.4506	1.9148	1.2899

 

Values were expressed as Mean ±SE., N=8,Values at the same column with different letters are significant at P<0.05

 

 

Effect Chelidonium majus L. roots extracts on FSH

Effect of Chelidonium majus L. roots extracts on total testosterone levels

It was observed clearly from Table 1 that testosterone levels (ng/ml) were more effect and decrease (P 0.05) in treated animals with cyclophosphamide (0.91-0.22) in comparison with the control negative group (1.83 0.15) while significantly increasing (P 0.05) in the treated group with Chelidonium majus L. Roots extracts at doses of 200mg (1.97-0.90), 300mg (2.11-0.44), and 400 mg (3.35±0.28) as opposed to the control positive group treated with cyclophosphamide at dose 14.2 mg/kg (0.91-0.22).

It was observed clearly from Table 1 that FSH levels (Iu/L) were noticeably decreased (P 0.05) in treated animals with cyclophosphamide (8.33 0.47) in comparison with the control negative group (13.24 0.70), while significantly increased (P 0.05) in the treated group with Chelidonium majus L. Roots extracts at doses 200mg (13.58 0.35), 300 mg (15.69 0.52), and 400 mg (16.27 0.30) as opposed to the control positive group treated with cyclophosphamide at dose 14.2 mg/kg (8.33 0.47).

Effect Chelidonium majus L. roots extracts on LH

It was observed clearly from Table 1 that LH levels (Iu/L) were noticeably decreased (P 0.05) in treated animals with cyclophosphamide (0.95 0.26) in comparison with the control negative group (1.95 0.51) while significantly increasing (P 0.05) in the treated group with Chelidonium majus L. Roots extracts at doses of 200mg (1.84 0.65), 300 mg (2.33 0.11), and 400 mg (2.79 0.11) as opposed to the control positive group treated with cyclophosphamide at dose 14.2 mg/kg (0.95 0.26).

 

 

Rats administered cyclophosphamide exhibited a significant reduction in sperm count, total testosterone levels, FSH, and LH. These findings are consistent with those reported by Ilbey et al. (2009) regarding the use of CP and other chemotherapeutic agents. The adverse effects of cancer treatments limit their effectiveness. Multiple studies have verified that CP’s adverse effects include toxicity to reproduction (Mohammadi et al., 2013, 2014). Cyclophosphamide (N, N-bis (2-chloroethyl) tetrahydro-2H-1, 3, 2-oxazaphosphorin-2-amine 2-oxide) is a nitrogenous mustard that belongs to the class of cytotoxic or cytostatic drugs (Aghaei et al., 2014; Yu et al., 1999). Traditional medicine employs CP extensively to treat a variety of diseases, including cancer. Cyclophosphamide (CP), the most extensively used immunosuppressive and anticancer drug, has a number of severe side effects, particularly on the reproductive system. Patients who require CP treatment have decreased fertility or infertility, which may affect their physical and emotional decisions to take the medication (Pavin et al., 2018).

 

Consumers who consume CP may experience numerous side effects, including reproductive interference. Due to the demonstrated testicular toxicity in multiple animal species, CP has a limited therapeutic effect (Elangovan et al., 2006). Oligospermia and azoospermia, as well as biochemical and histological alterations in the human and rat testis and epididymis, are associated with CP treatment (Masala et al., 1997; Kirkland et al., 1976). In CP-treated rodents, the toxic effect was manifested by a significant decrease in the number of spermatogonia, spermatocytes, and spermatozoa, and our results support those studies describing irregular and diminished seminiferous tubules with few germ cells in the CP group (Ilbey et al., 2009). In addition, patients who received CP exhibited symptoms of gonadotropin secretion problems, testicular injury, and decreased plasma testosterone levels (Hoorweg-Nijman, 1992). Chinese celandine contains numerous compounds with distinct biological properties and chemical structures, including flavonoids, phenolic acids, and alkaloids such as chelidonine, chelerythrine, sanguinarine, berberine, prototropine alkaline, allocryptine, and coptisine, among others. Various pharmacological activities (antioxidative, immunomodulatory, anticancer, hepatoprotective, analgesic, etc.) have been observed in both the crude extract and the purified fraction of C. majus (Paul et al., 2013) Chelidonium majus L. root extract exhibited a considerable increase in all tested parameters (sperm count, total testosterone levels, FSH, and LH) when administered to rats. These results concur with those of Khodabande et al. (2017).

Vitamin C, on the other hand, is an antioxidant molecule that is water-soluble. Vitamin C decreases free radicals after tissue injury. It has been demonstrated that vitamin C reduces tissue injury and enhances tissue function (Kabirian et al., 2018).

The importance of vitamin C’s anti-inflammatory properties cannot be overstated. It serves to reduce the tissue-damaging effects of reactive oxygen species (ROS) due to its inhibition of phospholipase A2 (Mohamed et al., 2013). In celandine, the primary secondary metabolites of flavonoids are phenolic compounds. Include antioxidant, anti-inflammatory, hypolipidemic, and anticancer activities (Lotito et al., 2006). Antioxidant compounds serve an essential role in protecting sperm in testicular tissue, and a deficiency of these compounds can result in infertility. In sperm and sperm-producing cells, this enzyme inhibits the harmful effects of DNA fragmentation (Milfard et al., 2011).

CONCLUSIONS AND RECOMMENDATIONS

In the treatment group, the use of Chelidonium majus L. root extract increased the values of the tested parameters, including sperm count, total testosterone levels, FSH, and LH. The group receiving cyclophosphamide had adverse reactions and side effects.

ACKNOWLEDGMENTS

We appreciate everyone involved in the project, and it was an honor to have the chance and pleasure to collaborate with them during the research. For their assistance in carrying out the study, the authors acknowledge the department of physiology and pharmacology at Baghdad University’s college of veterinary medicine.

NOVELTY STATEMENT

The novel study on the effect of Chelidonium majus L. Root Extract on cyclophosphamide-induced testicular toxicity in rats is an exciting development in the field of medicine and animal science. The potential of natural plant extracts to mitigate the adverse effects of chemotherapy is a fascinating avenue of research that could lead to improved outcomes for cancer cases.

AUTHRS’ CONTRIBUTION

All the authors contributed equally.

Conflict of interest

The authors have declared no conflict of interest.

REFERENCES

Aghaei S, Nikzad H, Taghizadeh M, Azami Tameh A, Taherian A (2014). Protective effect of Pumpkin seed extract on sperm characteristics, biochemical parameters and epididymal histology in adult male rats treated with Cy­clophosphamide. Andrologia, 46: 927-935. https://doi.org/10.1111/and.12175

Barnes J, Anderson L, Phillipson D (2007). The monograph: Celandine, greater. In herbal medicines: A guide for healthcare; pharmaceutical press: London, UK. pp. 136–145.

Barreto MC, Pinto RE, Arrabaça JD, Pavão ML (2003). Inhibition of mouse liver respiration by Chelidonium majus is quinoline alkaloids. Toxicol. Lett., 146: 37–47. https://doi.org/10.1016/j.toxlet.2003.09.007

Biswas SJ (2013). Chelidonium majus L. A review on pharmacological activities and clinical effects. J. Med. Plants, 2(4): 238–245.

Chyad AH (2017). Evaluation of anticancer, analgesic and anti-inflammatory activities of the ethanolic extract of lepidium draba linn. Leaves Adv. Anim. Vet. Sci., 5(1): 7-13. https://doi.org/10.14737/journal.aavs/2017/5.1.7.13

Dollery C (1999). Therapeutic drugs. Churchill livingstone, Ed­inburgh.

Elangovan N, Chiou TJ, Tzeng WF, Chu ST (2006). Cyclophosphamide treatment causes impairment of sperm and its fertilizing ability in mice. Toxicology, 222(1): 60-70. https://doi.org/10.1016/j.tox.2006.01.027

Erasmus N, Solomon M, Fortuin K, Henkel R (2012). Effect of Eurycoma longifolia Jack (Tongkat Ali) extract on human spermatozoa in vitro. Andrologia, 44: 308-314. https://doi.org/10.1111/j.1439-0272.2012.01282.x

European Medicines Agency (2021). Public statement on Chelidonium Majus L., Herba.

European Pharmacopoeia 9th Edition (2019). 9.7, Greater Celandine, Version Date 07/2012, Monographhy Number 1861. European Directorate for the Quality of Medicines and Healthcare, Strasbourg, France.

Falzone L, Salomone S, Libra M (2018). Evolution of cancer pharmacological treatments at the turn of the third millennium. Front. Pharmacol., 9: 1300. https://doi.org/10.3389/fphar.2018.01300

Fortini P, Marzio P, Guarrera PM, Iorizzi M (2016). Ethnobotanical study on the medicinal plants in the Mainarde mountains (Central-Southern Apennine, Italy). J. Ethnopharmacol., 184: 208–218. https://doi.org/10.1016/j.jep.2016.03.010

Groehler IVA, Villalta PW, Campbell C, Tretyakova N (2016). Covalent DNA–protein cross-linking by phosphoramide mustard and nornitrogen mustard in human cells. Chem. Res. Toxicol., 29(2): 190-202. https://doi.org/10.1021/acs.chemrestox.5b00430

Hartmann JT, Haap M, Kopp HG, Lipp HP (2009). Tyrosine kinase inhibitors–a review on pharmacology, metabolism and side effects. Curr. Drug. Metab., 10: 470–481. https://doi.org/10.2174/138920009788897975

He L, He T, Farrar S, Ji L, Liu T, Ma X (2017). Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species. Cell Physiol. Biochem., 44(2): 532–553. https://doi.org/10.1159/000485089

Hoorweg-Nijman JJ (1992). Cyclophosphamide-induced distur­bance of gonadotropin secretion manifesting testicular damage. Acta Endocrinol., 126(2): 143-148. https://doi.org/10.1530/acta.0.1260143

Hosseini A, Zare S, Ghaderi PF, Ahmadi A (2010). Effects of vitamin E and Ginseng extract on fertility changes induced by cyclophosphamide in rats. J. Reprod. Infert., 11(4): 227e37.

Huynh M, Stéphanie Piazza DMV (2020). Neurologic examination. Ferrets, Rabbits and Rodents-E-Book: Clin. Med. Surg., 117. https://doi.org/10.1016/B978-0-323-48435-0.00010-1

IAEC (Institutional Animal Ethics Committee) (2010). Commit for the purpose of control, supervision of experiments on animals (CPCSEA) CPCSEA is guidelines for laboratory animal facility.

Ilbey YO, Ozbek E, Simsek A, Otunctemur A, Cek­men M, Somay A (2009). Potential chemoprotective effect of mela­tonin in cyclophosphamide-and cisplatin-induced testicu­lar damage in rats. Fertil. Steril. 92(3): 1124-1132. https://doi.org/10.1016/j.fertnstert.2008.07.1758

Johari H, Mahmoudinejad F, Amjad G (2011). Evaluate the effect of ginger extract on the axis hypothalamus, pituitary, gonadal axis in adult female rats (Rat) treated with cyclophosphamide. J. Pzhvda, 6(20): 62-70.

Kabirian F, Ditkowski B, Zamanian A, Heying R, Mozafari M (2018). An innovative approach towards 3D-printed scaffolds for the next generation of tissue-engineered vascular grafts. Materials today: Proceedings, 5(7): 15586-15594. https://doi.org/10.1016/j.matpr.2018.04.167

Kasper S, Dennis L, Braunwald K, Eugene L, Fauci K, Anthony F (2005). Harrison’s principles of internal medicine. 16th ed. pp. 453-469.

Khodabande Z, Jafarian V, Sariri R (2017). Antioxidant activity of Chelidonium majus extract at phenological stages. Appl. Biol. Chem., 60(5): 497–503. https://doi.org/10.1007/s13765-017-0304-x

Kirkland R, Bongiovanni AM, Cornfeld D, McCormick JB, Parks JS (1976). Gonadotropin responses to luteinizing releasing factor in boys treated with cyclophosphamide for nephrot­ic syndrome. J. Pediatr., 89: 941-944. https://doi.org/10.1016/S0022-3476(76)80600-2

Kujawska M, Klepacki P, Łuczaj Ł (2017). Fischer’s plants in folk beliefs and customs: A previously unknown contribution to the ethnobotany of the polish-lithuanian-belarusian borderland. J. Ethnobiol. Ethnomed., 13: 1–15. https://doi.org/10.1186/s13002-017-0149-8

Lotito SB, Frei B (2006). Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: Cause, consequence, or epiphenomenon? Free Radic. Biol. Med., 41(12): 1727–1746. https://doi.org/10.1016/j.freeradbiomed.2006.04.033

Manikowska K, Mikołajczyk M, Mikołajczak PŁ, Bob-kiewicz-Kozłowska T (2014). The influence of mianserin on TNF-a, IL-6 and IL-10 serum levels 4 in rats under chronic mild stress. Pharmacol. Rep., 66: 22-27. https://doi.org/10.1016/j.pharep.2013.06.003

Masala A, Faedda R, Alagna S, Satta A, Chiarelli G, Rova­sio PP (1997). Use of testosterone to prevent cyclophosphamide-induced azoospermia. Ann. Intern. Med., 126: 292-295. https://doi.org/10.7326/0003-4819-126-4-199702150-00005

McGaha TL, Huang L, Lemos H, Metz R, Mautino M, Prendergast GC (2012). Amino acid catabolism: A pivotal regulator of innate and adaptive immunity. Immunol. Rev., 249(1): 135-157. https://doi.org/10.1111/j.1600-065X.2012.01149.x

Menković N, Šavikin K, Tasić S, Zdunić G, Stešević D, Milosavljević S (2011). Ethnobotanical study on traditional uses of wild medicinal plants in Prokletije mountains (Montenegro). J. Ethnopharmacol., 133: 97–107. https://doi.org/10.1016/j.jep.2010.09.008

Mirfard M, Johari H, Mokhtari M (2011). The effect of hydro-alcoholic garlic extract on testis weight and spermatogenesis in mature male rats under chemotherapy with cyclophosphamide. J. Fasa Univ. Med. Sci., 1(3): 123-130.

Mohammadi F, Nikzad H, Taghizadeh M, Moravveji SA (2013). Effect of pumpkin extract regimen on testicular struc­ture and serum biochemical parameters in cyclophospha­mide-treated adult rats. KAUMS J. (FEYZ), 17(5): 438-446.

Mohammadi F, Nikzad H, Taghizadeh M, Azami-Tameh A, Hosseini M (2014). Protective effect of Zingiber officinale extract on rat testis after cyclophosphamide treatment. Androlo­gia, 46: 680-686. https://doi.org/10.1111/and.12135

Naglaa RK, Fathia AM, Khaled GAW, Hagar HM, Heba FG (2022). Preventive efficiency of Chelidonium majus ethanolic extract against aflatoxin B1 induced neurochemical deteriorations in rats. Pak. J. Biol. Sci., 25(3): 234-244. https://doi.org/10.3923/pjbs.2022.234.244

Nelius T, Klatte T, DeRiese W, Haynes A, Filleur S (2010). Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated.

Paul A, Das J, Das S, Samadder A, Khuda-Bukhsh AR (2013). Poly (lactide-co-glycolide) nano-encapsulation of chelidonine, an active bioingredient of greater celandine (Chelidonium majus), enhances its ameliorative potential against cadmium induced oxidative stress and hepatic injury in mice. Environ. Toxicol. Pharmacol., 36(3): 937–947. https://doi.org/10.1016/j.etap.2013.08.008

Pavin NF, Izaguirry AP, Soares MB, Spiazzi CC, Mendez AS, Leivas FG (2018). Tribulus terrestris protects against male reproductive damage induced by cyclophosphamide in mice. Oxid. Med. Cell Longev., 20(18): 1-9. https://doi.org/10.1155/2018/5758191

Petr M, Navratil T, Heyrovsky M, Kohlikova E (2011). The role of supplemented creatine in human metabolism. Curr. Org. Chem., 15(17): 3029-3042. https://doi.org/10.2174/138527211798357083

Rezvanfar M, Sadrkhanlou RA (2008). Protection of cyclophos­phamide-induced toxicity in reproductive tract histology, sperm characteristics, and DNA damage by an herbal source; evidence for role of free-radical toxic stress. Hum. Exp. Toxicol., 27(12): 901-910. https://doi.org/10.1177/0960327108102046

Saha B, Bhattacharyya S, Mete S, Mukherjee A, Priyadarsi D (2019). Redox-driven disassembly of polymer–chlorambucil polypro drug: Delivery of anticancer nitrogen mustard and dna alkylation. ACS Appl. Polym. Mater., 1(9): 2503–2515 https://doi.org/10.1021/acsapm.9b00616.

Sakamato, J. and Hashimoto, K. (1986). Reproductive toxicity of acrylamide and related compounds in mice. Effect on fertility and sperm morphology. Arch. Toxicol., 95: 201-205.

SAS (2014). Statistical analysis system, user’s guide. Statistical. Version 9.1th ed. SAS. Inst. Inc. Cary. N.C. USA.

Selvakumar E, Prahalathan C, Mythili Y, Varalakshmi P (2005a). Beneficial effects of DL-a-lipoic acid on cyclophospha­mide-induced oxidative stress in mitochondrial fractions of rat tes­tis. Chem. Biol. Interact., 152: 59–66. https://doi.org/10.1016/j.cbi.2005.01.009

Sile I, Romane E, Reinsone S, Maurina B, Tirzite D, Dambrova M (2020). Data on medicinal plants in the records of latvian folk medicine from the 19th century. J. Ethnopharmacol., 28: 105024. https://doi.org/10.1016/j.dib.2019.105024

Takimoto CH, Calvo E (2005). Principles of oncologic pharmacotherapy. In: Pazdur, R., Coia, L.R. and Hoskins, W.J. cancer management: A multidisciplinary approach. 9th ed. pp. 23-42.

Yu LJ, Drewes P, Gustafsson K, Brain EG, Hecht JE, Waxman DJ (1999). In vivo modulation of alternative pathways of P-450 catalyzed cyclophosphamide metabolism: Impact on pharmacokinetics and antitumor activity. J. Pharmacol. Exp. Ther., 288(3): 928–937.

Zielinska S, Jezierska-Domaradzka A, Wójciak-Kosior M, Sowa I, Junka A, Matkowski AM (2018). Greater Celandine’s ups and downs 21 centuries of medicinal uses of Chelidonium majus from the viewpoint of today’s pharmacology. Front. Pharm., 9: 1–29. https://doi.org/10.3389/fphar.2018.00299

Zielinska S, Wójciak-Kosior M, Dzia˛gwa-Becker M, Glen´sk M, Sowa I, Fijałkowski K (2019). The activity of is quinoline alkaloids and extracts from Chelidonium majus against pathogenic bacteria and Candida sp. Toxins, 11: 406. https://doi.org/10.3390/toxins11070406